Introduction. Since colorectal cancer (CRC) is the second most commonly diagnosed
malignancy in Europe and third worldwide, novel biomarkers for diagnosing the disease are …

PURPOSE: Serum CXCL5 levels in patients with colorectal cancer (CRC) were assessed to
evaluate correlation with clinicopathologic features and prognosis. The effects of CXCL5 on …

Purpose This study was designed to identify novel and reliable serum prognostic markers in
patients with colorectal cancer (CRC). Methods Based on cytokine array analysis, we …

Background. The CXC chemokines belong to a unique family of chemotactic cytokines that
influence the initiation, progression, and clinical outcome of many tumor types. Herein, we …

Due to the lack of typical symptoms and signs and sensitive indicators for early diagnosis of
obstructive colorectal cancer (OCRC), it is critically needed to find new novel biomarkers to …

The CXCL10/CXCR3 axis of inflammatory mediators is one of the most important groups of
chemokine axes, which has been proven to be a lymphocyte‑associated metastasis …

The aim of this study was to identify novel and reliable serum markers related to the
prognosis of colorectal cancer (CRC) patients and to assess the association between …

Abstract CXC Chemokine Ligand 10 (CXCL10), an interferon-inducible protein, has been
demonstrated to inhibit the proliferation and metastasis in many tumors. In this study, we …

Abstract CXC motif chemokine 8 (CXCL-8), known as interleukin-8, is a pro-inflammatory
cytokine which acts as a chemotactic factor, mainly for leukocytes. CXCL-8 is produced by …

Background The role of CXCL10 in progression and prognosis of colorectal cancer (CRC)
has been studied for years, yet results remain controversial. Aim This study aims to explore …